NCT02493738View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Superficial MycosesDermatomycosesCandidiasisHistoplasmosis
Interventions
DRUG

Lozanoc 50mg

Lozanoc 50mg single dose under fed and fasted condition

DRUG

Sporanox 100mg

Sporanox 100mg single dose under fed condition

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY